‘Biotech Company Leading Precision Medicine’
Theragen Bio is a company that leads precision medicine, which will be highlighted as a new paradigm of future medicine of Korea in the era of the Fourth Industrial Revolution.
The company provides a wide range of services such as customized diagnostic solutions and next-generation sequencing (NGS), clinical and medical big data business based on state-of-the-art genome sequencing and analysis technologies.
Theragen Bio, which became Korea’s representative genome company with a sales increase of more than 40% for three consecutive years since 2015, also stands out on the international stage, and is currently exporting related technologies to 40 or more countries.
The ultimate goal of Theragen Bio is not high sales and profit. The ultimate goal is to proactively lead the bio industry for it to become a growth engine for Korea’s future and lay the foundation for the next generations to conduct research on biotechnology and grow as global scientists.
The company will make its best efforts to grow into Korea’s representative bio company and become a great company respected by people by contributing to our nation and society.
We will become a sincere platform that connects the present and the future, and Korea and the world.
Thank you for being with Theragen Bio!
CEO and President